Position in MRK
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$11,181,684
+$190,547 QoQ
Shares Held
87,017
-4.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#710
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRILLIUM ASSET MANAGEMENT, LLC holds $65,640,925 across 8 Drug Manufacturers - General names. MRK ranks #2 (17.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
208,971 | $39,625,081 | |
| 2 | MRK |
Merck & Co., Inc.
This page
|
87,017 | $11,181,684 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
75,118 | $9,490,408 | |
| 4 | JNJ |
Johnson & Johnson
|
11,314 | $2,873,416 | |
| 5 | NVO |
Novo Nordisk A S
|
19,689 | $943,890 | |
| 6 | ABBV |
AbbVie Inc.
|
2,843 | $715,412 | |
| 7 | LLY |
ELI LILLY & Co
|
359 | $430,595 | |
| 8 | PFE |
Pfizer Inc
|
15,799 | $380,439 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,181,684 | 87,017 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $10,991,137 | 91,372 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $10,125,275 | 96,193 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $8,831,702 | 105,227 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $8,991,071 | 113,581 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $11,532,634 | 128,483 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $37,693,469 | 378,905 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $44,551,972 | 392,321 | Shares | Defined | 2024-11-07 | |
| 2024-06-30 | $49,284,036 | 398,094 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $61,023,707 | 462,476 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $50,754,369 | 465,551 | Shares | Other | 2024-02-08 | |
| 2023-09-30 | $49,199,495 | 477,897 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $58,801,935 | 509,593 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $54,258,686 | 509,998 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $51,857,585 | 467,396 | Shares | Other | 2023-02-08 | |
| 2022-09-30 | $41,149,427 | 477,815 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $43,957,524 | 482,149 | Shares | Other | 2022-08-08 | |
| 2022-03-31 | $35,420,409 | 431,693 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $35,416,876 | 462,120 | Shares | Other | 2022-02-08 | |
| 2021-09-30 | $34,155,295 | 454,737 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $34,165,293 | 439,312 | Shares | Other | 2021-11-12 | |
| 2021-03-31 | $33,313,689 | 432,140 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $40,979,490 | 500,972 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $41,414,381 | 499,269 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $41,277,611 | 533,785 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $40,718,861 | 529,229 | Shares | Other | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||